Free Trial

Neogen (NEOG) Competitors

Neogen logo
$10.04 0.00 (0.00%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$10.04 0.00 (0.00%)
As of 02/21/2025 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEOG vs. MMSI, ICUI, XRAY, HAE, QDEL, STAA, CERS, OSUR, ANIK, and UTMD

Should you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry.

Neogen vs.

Neogen (NASDAQ:NEOG) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neogen$913.83M2.38-$9.42M-$2.19-4.58
Merit Medical Systems$1.26B4.78$94.41M$2.0450.57

In the previous week, Neogen had 13 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for Neogen and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.49 beat Neogen's score of -0.20 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Merit Medical Systems
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Neogen currently has a consensus target price of $14.00, suggesting a potential upside of 39.44%. Merit Medical Systems has a consensus target price of $109.80, suggesting a potential upside of 6.44%. Given Neogen's higher probable upside, equities research analysts clearly believe Neogen is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Merit Medical Systems
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.00

Merit Medical Systems received 111 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 69.72% of users gave Merit Medical Systems an outperform vote while only 56.58% of users gave Neogen an outperform vote.

CompanyUnderperformOutperform
NeogenOutperform Votes
331
56.58%
Underperform Votes
254
43.42%
Merit Medical SystemsOutperform Votes
442
69.72%
Underperform Votes
192
30.28%

Merit Medical Systems has a net margin of 9.05% compared to Neogen's net margin of -52.12%. Merit Medical Systems' return on equity of 15.61% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Neogen-52.12% 2.89% 1.98%
Merit Medical Systems 9.05%15.61%8.38%

96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.1% of Neogen shares are owned by company insiders. Comparatively, 3.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Neogen has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.

Summary

Merit Medical Systems beats Neogen on 16 of the 19 factors compared between the two stocks.

Get Neogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEOG vs. The Competition

MetricNeogenDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$2.18B$2.19B$5.77B$8.98B
Dividend YieldN/A0.75%4.78%3.85%
P/E Ratio-4.585.0426.4618.82
Price / Sales2.3887.03453.2580.30
Price / Cash10.0415.7944.0437.47
Price / Book0.693.287.634.64
Net Income-$9.42M-$65.73M$3.18B$245.69M
7 Day Performance2.14%-3.90%-1.91%-2.66%
1 Month Performance-15.98%-8.97%-0.19%-2.15%
1 Year Performance-41.66%-15.59%16.70%12.90%

Neogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEOG
Neogen
3.7023 of 5 stars
$10.04
flat
$14.00
+39.4%
-41.5%$2.18B$913.83M-4.582,110
MMSI
Merit Medical Systems
3.6411 of 5 stars
$108.14
-0.2%
$109.80
+1.5%
+30.1%$6.30B$1.26B53.016,950Positive News
ICUI
ICU Medical
4.664 of 5 stars
$160.16
+1.2%
$199.67
+24.7%
+51.1%$3.92B$2.26B-35.0514,000News Coverage
XRAY
DENTSPLY SIRONA
4.8578 of 5 stars
$18.32
-2.4%
$25.85
+41.1%
-43.3%$3.64B$3.97B-8.8515,000Analyst Upgrade
HAE
Haemonetics
4.7365 of 5 stars
$62.47
+0.3%
$101.67
+62.8%
-14.0%$3.14B$1.31B24.593,657Analyst Revision
QDEL
QuidelOrtho
4.7925 of 5 stars
$40.57
-2.6%
$51.20
+26.2%
-18.2%$2.73B$3.00B-1.457,100
STAA
STAAR Surgical
4.6378 of 5 stars
$15.35
-3.8%
$26.86
+75.0%
-44.5%$756.45M$322.42M34.891,115High Trading Volume
CERS
Cerus
2.8625 of 5 stars
$1.85
+2.8%
$3.63
+95.9%
-26.3%$343.57M$176.23M-16.82290Earnings Report
Analyst Forecast
News Coverage
Positive News
OSUR
OraSure Technologies
4.1472 of 5 stars
$3.93
+1.0%
$5.50
+39.9%
-44.8%$293.14M$405.47M26.20840
ANIK
Anika Therapeutics
2.8386 of 5 stars
$17.86
+1.2%
$24.50
+37.2%
-29.3%$261.65M$166.66M-2.69300
UTMD
Utah Medical Products
3.6048 of 5 stars
$61.05
-1.2%
N/A-15.9%$206.96M$40.90M15.46180Positive News

Related Companies and Tools


This page (NASDAQ:NEOG) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners